Curriculum Vitae PERSONAL INFORMATION Peter Caspers WORK EXPERIENCE June 1988–March 1991 Pharmacist Apotheek Lamberts IJsselstein, (Netherlands) Managing a local, public pharmacy April 1991–October 1999 Pharmacist Apotheek Montfoort, Montfoort, (Netherlands) Managing a local, public pharmacy October 1999–May 2011 Pharmaceutical assessor RIVM, Bilthoven, (Netherlands) Assessment of the chemical-pharmaceutical sections of drug product application dossiers, Research on behalf of the Dutch Healthcare Inspectorate June 2011–Present Pharmaceutical assessor Dutch Medicines Evaluation Board, (Netherlands) Assessment of the chemical-pharmaceutical sections of drug product application dossiers EDUCATION AND TRAINING September 1980–May 1988 Msc Mathematics and Physics, Pharmacy; pharmacist University of Utrecht, (Netherlands) Pharmaceutics, pharmacotherapeutics ADDITIONAL INFORMATION Expertise Chemical-pharmaceutical Multivariate data analysis Near-Infrared spectroscopy Process analytical technology Therapeutical equivalence Biowaivers Inhalation products Specific dosage forms Public pharmacy Drug eluting stents and ballooncatheters Publications Vredenbregt MJ, Caspers PWJ, Hoogerbrugge R, Barends D; Choice and validation of a near infrared spectroscopic application for the identity control of starting materials; practical experience with the EU draft Note for Guidance on the use of near infrared spectroscopy by the pharmaceutical industry an the data to be forwarded in part II of the dossier for a marketing authorization, European Journal of Pharmaceutics and Biopharmaceutics 56 (2003) 489-499. Caspers PWJ, E.K. de Rooij-Lamme, D de Kaste. Semi-industrial manufacture of drug products in Dutch pharmacies. Quality and legitimacy. RIVM rapport 267021001/2005 Matthijs L. Becker, Peter W. J. Caspers, Marjon Kallewaard, Riekert J. Bruinink, Nico B. Kylstra, Siem 20/11/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 1 / 2 Curriculum Vitae Peter Caspers Heisterkamp, Vincent de Valk, Andre´ A. van der Veen, Bruno H. Ch. Stricker.. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands. Pharm World Sci (2007) 29:51-57 Hadassa Jochemsen, Ronald Gijsen, Peter Caspers. Off-label voorschrijven: medisch handelen en motieven van huisartsen. Huisarts en Wetenschap 50(5) mei 2007. R Gijsen, H Jochemsen, L van Dijk, P Caspers. Frequency of ill-founded off-label prescribing in Dutch general practice. Pharmacoepidemiology and Drug Safety, 2008;17:1-8 Caspers PWJ, Gijsen R, Blokstra A. Off-label gebruik van geneesmiddelen. RIVM rapport 370050001/2007 Projects Memberships OMCL Annual meeting 13 – 17 May 2002, Bilthoven, the Netherlands :’Verification of the identity of pharmaceutical substances with near-infrared spectroscopy’. VfA Workshop Process Analytical Technologies, ACHEMA – Frankfurt a/M 19 May 2003: ‘CPMP/QWP Note for Guidance on NIRS’ Process Analytical Technology, IQPC Conference, 23-24 June 2004, London,” Understanding the implications and future direction of the EMEA/CPMP Note for Guidance on NIRS”. Stability Testing Summit, Vision in Business, London 29-30 November 2004: ‘Developing ICH compliant stability protocols: a national authorities perspective’. European Registration Authorities Requirements for NIR Applications, Concept Heidelberg, 13-14 September 2005. PAT and the regulatory authorities. PAT Seminar. NL/BE Pat Forum. Oss, 29th September 2006 Biowaivers and dissolution testing for specific product types. HMA Assessor’s training Prague 19-20 April 2012 Other Relevant Information 20/11/14 © European Union, 2002-2014 | http://europass.cedefop.europa.eu Page 2 / 2